Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.10% | -73.83% | -80.49% | -80.43% | -58.94% |
| Total Depreciation and Amortization | 6.53% | 2.21% | 4.15% | 4.15% | 10.88% |
| Total Amortization of Deferred Charges | 20.29% | 8.88% | 17.61% | 17.61% | 58.05% |
| Total Other Non-Cash Items | -17.21% | -17.93% | 831.31% | 229.66% | 180.12% |
| Change in Net Operating Assets | 75.36% | 143.63% | 76.99% | 76.99% | -21.31% |
| Cash from Operations | 18.87% | 39.83% | -9.56% | -5.04% | -13.39% |
| Capital Expenditure | 33.51% | 28.84% | 14.79% | -11.68% | -9.42% |
| Sale of Property, Plant, and Equipment | 507.35% | 520.44% | -62.47% | -57.02% | -89.81% |
| Cash Acquisitions | -1,525.28% | -5.10% | -4.67% | -4.03% | 91.37% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 141.81% | 111.61% | -995.54% | -345.05% | -291.54% |
| Cash from Investing | 126.30% | 98.65% | -374.65% | -202.07% | -181.70% |
| Total Debt Issued | -51.16% | -11.84% | 14.41% | 5.59% | -10.78% |
| Total Debt Repaid | -45.92% | -79.23% | -65.55% | -51.28% | -0.63% |
| Issuance of Common Stock | 23.63% | -5.37% | 10.41% | -12.70% | -23.39% |
| Repurchase of Common Stock | -108.78% | -108.78% | -422.28% | -422.28% | 38.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 40.79% | -42.14% | -11.55% | -9.50% | -3.79% |
| Other Financing Activities | 83.05% | 96.48% | 35.57% | 15.39% | -502.89% |
| Cash from Financing | -311.69% | -548.82% | -511.34% | -9,085.42% | -246.75% |
| Foreign Exchange rate Adjustments | 149.85% | 136.91% | -81.70% | -176.32% | 27.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.35% | 69.93% | -5,092.22% | -1,320.11% | -1,604.57% |